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Abstract
Innate immunity provides frontline antiviral protection and bridges adaptive immunity against
virus infections. However, viruses can evade innate immune surveillance potentially causing
chronic infections that may lead to pandemic diseases. Porcine reproductive and respiratory
syndrome virus (PRRSV) is an example of an animal virus that has developed diverse
mechanisms to evade porcine antiviral immune responses. Two decades after its discovery,
PRRSV is still one of the most globally devastating viruses threatening the swine industry. In this
review, we discuss the molecular and cellular composition of the mammalian innate antiviral
immune system with emphasis on the porcine system. In particular, we focus on the interaction
between PRRSV and porcine innate immunity at cellular and molecular levels. Strategies for
targeting innate immune components and other host metabolic factors to induce ideal anti-
PRRSV protection are also discussed.
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Introduction
The immune system in higher vertebrates involves
both innate and adaptive immune responses (Pancer
and Cooper, 2006). Innate immune mechanisms, which
exist in all organisms from bacteria to humans, provide
immediate frontline protection against infections (Beutler,
2004; Pancer and Cooper, 2006). Evidence from both the
host and virus indicates that invoking early and appro-
priate innate immune responses is critical for the outcome
of most viral diseases, determining whether an infection is
controlled or whether a persistent infection develops
(Beutler, 2004; Pancer and Cooper, 2006). The critical role
of innate immune cells and their components not only
dominates antiviral activity in the early phase of infection,
but also potentiates the adaptive immune system for viral
clearance (Hoebe et al., 2004; Kabelitz and Medzhitov,
2007). In this review, we provide a brief discussion of the
major components of the innate antiviral immune system
with particular emphasis on porcine-specific features.
Our emphasis is on the response to and subversion of
porcine innate antiviral immunity during infection caused
by porcine reproductive and respiratory syndrome virus
(PRRSV). For more general discussions about the chal-
lenges of PRRSV immunology and vaccinology, the reader
is referred to several recent reviews (Kimman et al., 2009;
Darwich et al., 2010; Yoo et al., 2010).
Overview of mammalian innate antiviral
immune system
Innate immune cells
A highly differentiated immune system appears to offer
an evolutionary advantage to higher vertebrates. None-
theless, all nucleated cells are readily capable of mounting*Corresponding author. E-mail: blecha@vet.k-state.edu
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innate immune responses upon exposure to a virus
(Beutler, 2004). Mammalian innate immune cells, which
are specialized for various functions such as pathogen
recognition and killing, immune surveillance and antigen
presentation, include granulocytes, natural killer (NK)
cells, macrophages and dendritic cells (DCs), as well as
epithelial and endothelial cells. Granulocytes, macro-
phages and NK cells are well documented for their role as
effector cells in engulfing and digesting microorganisms
or promoting active death of infected cells (Ludwig et al.,
2006; Appelberg, 2007; Takeuchi and Akira, 2007; Vivier
et al., 2008). Depending on their anatomical locations,
epithelial and endothelial cells, as well as DCs and
macrophages, are among the first groups of cells initially
exposed to viruses (Barchet et al., 2005; Opitz et al., 2007;
Wen et al., 2008; Hammad and Lambrecht, 2008). Their
function in viral recognition and immune surveillance
facilitates coordination of subsequent immune responses
by linking to adaptive immunity.
Innate immune cells are dually functional as ‘sensors’
and ‘effectors’. Even cells that are primarily associated
with killing, e.g., neutrophils, facilitate immune surveil-
lance via Toll-like receptors (TLRs) (Haselmayer et al.,
2006; Borregaard et al., 2007). Furthermore, professional
antigen presenting cells, such as conventional DCs,
potently destroy engulfed pathogens through autophagy
(Schmid et al., 2006; Lee and Iwasaki, 2008). This
functional plasticity is best known in macrophages, which
are composed of diverse subgroups of professional
phagocytes as well as immunoregulatory cells (Figure 1;
Hashimoto et al., 2007; Kumagai et al., 2007; Randolph
et al., 2008). Because innate immune cells such as
macrophages, epithelial cells and endothelial cells, often
serve as the initial foothold for viral infection, these cells
provide an excellent platform for examining virus–host
interaction, viral recognition, signaling transduction and
antiviral effector function (Opitz et al., 2007; Hammad
and Lambrecht, 2008; Wen et al., 2008).
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Fig. 1. Innate immune homeostasis and interaction with viral infection. Innate immune cells exert antiviral activities of
immune surveillance and direct inactivation using various virus-sensing and effector molecules. Whereas most viral attacks are
controlled through innate immunity and synergistic induction of adaptive immunity (including vaccine-induced), virus isolates
or species that have the capability to divert innate immunity, especially type I IFN responses, alter innate immune balance
causing pandemic diseases (Katze et al., 2008).
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Accumulated evidence indicates that upon viral infec-
tion the overall immune response is dependent on the
coordination of innate immune cells to exert immune
surveillance and to produce immune effectors. The
balance resulting from immune regulation or vaccine-
induced innate-immune activation will elicit both
innate and adaptive immunity to control virus replication.
In contrast, if viruses divert the induction of innate im-
munity, especially a type I interferon (IFN) response, it is
likely that disease will result from uncontrolled viral
infections (Figure 1; Katze et al., 2008). DCs and activated
macrophages are antigen-presenting cells, which directly
bridge innate and adaptive immunity. In addition, some
newly defined groups of innate immune cells including
innate lymphoid cells (ILCs), natural helper cells (NHCs)
and innate type 2 helper cells (ih2), which are crucial
for the development of lymphoid structures and secrete
cytokines similar to those from T helper cells, are also
important players that bridge innate and adaptive im-
munity. However, their role in antiviral responses remains
obscure (Sawa et al., 2010; Saenz et al., 2010; Veldhoen
and Withers, 2010).
Monocytes represent 10–30% of all peripheral
blood mononuclear cells (PBMC) and are progenitors of
most tissue macrophages (Randolph et al., 2008; Cassol
et al., 2010). These myeloid monocytes circulate for about
1–2 days before migrating into peripheral tissues and
differentiating into resident tissue macrophages (Martinez
et al., 2009). Macrophages are anatomically and function-
ally heterogeneous. Tissue-specific macrophages are
specific to anatomic locations including blood monocytes,
peritoneal macrophages, pulmonary macrophages,
Kupffer cells in the liver and microglia in the brain
(Taylor et al., 2005; Naito, 2008; Randolph et al., 2008).
Even within an organ, macrophages are further categor-
ized based on their micro-anatomical location. The lung
provides an example of this macrophage categorization.
For example, pulmonary macrophages can be divided
into three subgroups based on their microenvironment
within the lung: pulmonary alveolar macrophages
(PAMs), pulmonary intravascular macrophages (PIMs)
and interstitial macrophages (ISMs) (Naito, 2008;
Randolph et al., 2008).
PAMs are the most abundant pulmonary immune cells
in the alveolus located at the interface between air and
lung tissues. Substantial numbers of ISMs are detected
within the lung stroma and PIMs are mature phagocytes
adhered to capillary endothelial cells within the lung that
cover approximately 16% of the lung capillary surface in
species such as pigs and ruminants (Chitko-McKown and
Blecha, 1992). With respect to airway viral infections,
PAMs are first to express early activation for scavenging
and killing mucus-trapped viral particles through phago-
cytosis. To fulfill this task, activated PAMs are equipped
with a variety of surface and internal receptors to detect
antibody/complement-engaged viral particles (by surface
Fc or complement receptors) and to recognize viral
components by membrane-associated or cytosolic recep-
tors (Fantuzzi et al., 2003; Beisswenger and Bals, 2005;
Daffis et al., 2007; Kumagai et al., 2007). PAMs are very
active killer cells known to inactivate trapped viruses with
both oxidative and non-oxidative mechanisms and to
lower the chance of airborne viruses initializing infections
on pneumocytes as well as pulmonary endothelial cells
(Taylor et al., 2005; Naito, 2008; Randolph et al., 2008).
PAMs are activated through phagocytosis or receptor
recognition of viral components. They are active produ-
cers of type I IFNs and other pro-inflammatory cytokines,
which lead to antiviral responses including the regulatory
loop by type I IFNs and recruitment of other immune cells
to infection sites (Kumagai et al., 2007; Takeuchi and
Akira, 2007). Normally, PAMs represent >90% of immune
cells in bronchoalveolar lavage (BAL) fluid prior to the
increase of granulocytes in BAL fluid after an infection
(White et al., 2007). PAMs have been identified as the
primary IFN-a producer in murine models upon respira-
tory viral infections (Kumagai et al., 2007; Takeuchi and
Akira, 2007).
Compared to PAMs, ISMs are less phagocytic and
potentially more active in repairing tissue damage. PIMs
are highly phagocytic and mainly exist in ruminants, pigs
and horses (Longworth, 1997). Compared to PAMs,
porcine PIMs are almost equally permissive to PRRSV
infection and their bactericidal and phagocytic activities
are significantly suppressed by PRRSV infection much like
PAMs (Thanawongnuwech et al., 2000).
The importance of macrophages in an antiviral immune
response is also reflected by the virus’ ability to surpass
this first line of surveillance allowing for a much higher
chance of escaping innate immune defenses in turn
causing persistent infections. Several viruses possess
the ability to directly infect and undermine immune
responses (such as production and signaling of type I
IFNs) of macrophages (Table 1). For example, macro-
phages infected by human immunodeficiency virus-1
(HIV-1) and PRRSV are functionally compromised in
many ways including cytokine production, receptor
expression, phagocytosis and antigen presentation (Ieong
et al., 2000; Martinelli et al., 2007; Darwich et al., 2010;
Thanawongnuwech and Suradhat, 2010). In this regard,
direct infection of macrophages may divert overall
homeostasis of cell activation status causing exacerbating
co-infections and complicated syndromes.
Macrophages have been classified into two major
types according to their activation status and functional
difference: the classical type 1 macrophages (M1) and
alternative type 2 macrophages (M2). M1 cells are
conventionally activated by Th1 cytokines such as IFN-g
and IL-12. Alternatively, M2 macrophages are more
heterogeneous than M1 cells depending on the stimuli.
M2a macrophages are induced by Th2 cytokines such as
IL-4/IL-13, while M2b macrophages are activated by
immune complexes, TLR stimulation, or by IL-1Ra. M2c
macrophages are generated by stimulation with the
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Table 1. Innate immune evasion mechanisms of various monocytotropic viruses
Virus: [genome, family] PRRs* Mechanism and effect on type I IFN and other cytokine production* References
HRSV: [()ssRNA,
Paramyxoviridae]
Multiple TLRs,
RIG-I, PKR
Viral NS1 and NS2 proteins inhibit IFN production and signaling;
stimulates the production of Th2 cytokines and IL-10 to skew
alternative activation of macrophages
Schlender et al. (2005),
Munir et al. (2008),
Shirey et al. (2010)
IVA: [Segmented ()RNA,
Orthomyxoviridae]
Multiple TLRs and RLRs NS1 gene product inhibits IFN secretion and activity; suppresses
IL-8 production; pandemic strains may skew M2b and Th2 response
through immune complexes
Ehrhardt (2010),
Koyama et al. (2007),
Calzada-Nova et al. (2010a, b),
Monsalvo et al. (2011)
SARS-CoV: [(+)ssRNA,
Coronaviridae]
MyD88-dependent TLRs A papain-like protease inhibits IFN secretion via IRF3 interference;
elevates pro-inflammatory cytokines and chemokines in lung and
blood
Chen and Subbarao (2007),
Devaraj et al. (2007),
Sheahan et al. (2008)
HIV1: [(+)ssRNA, Retroviridae] Multiple TLRs Skews M1 activation at acute phase for establishing viral reservoirs
and M2 macrophages transmission and leads to immune failure at
late stages
Thibault et al. (2009),
Sanders et al. (2008),
Herbein and Varin (2010)
SeV: [()ssRNA, Paramyxoviridae] Multiple TLRs and RLRs Sendai virus C protein blocks signal transduction of IFN Kato et al. (2007),
Bousse et al. (2006)
CSFV: [(+)ssRNA, Flaviviridae] Multiple TLRs Viral protein N mediates IRF3 degradation and suppresses IFN
production, but no modulation of IL-10 and pro-inflammatory cytokines
Carrasco et al. (2004),
Bauhofer et al. (2007)
PrV: [dsDNA, Herpesviridae] Viral DNA sensors? Viral EP0 protein targets STAT1 to prevent IFN-induced antiviral state;
may suppress IL-12 production
Brukman and Enquist (2006a, b),
Calzada-Nova et al. (2010a, b)
ASFV: [dsDNA, Asfarviridae] TLR3 Strain-dependent suppression of TLR3 signaling and IFN response;
highly virulent strains are more potent suppressors of IFN and
pro-inflammatory cytokine production
Afonso et al. (2004),
Zhang et al. (2006),
Gil et al. (2008),
de Oliveira et al. (2011)
PCV2: [ssDNA, Circoviridae] Possible TLR7/9 Impairs TLR9 ligand-induced IFN and pro-inflammatory cytokine
production; stimulates IL-10 production of bystander T cells
but not infected macrophages
Chang et al. (2006),
Vincent et al. (2007),
Wikstro¨m et al. (2011)
PFMDV: [(+)ssRNA,
Picornaviridae]
TLR7/8 Viral L protein mediates suppression of IFN synthesis and ISG
induction; induces IL-10 production of pDCs during acute
phase for immune suppression
de Los Santos et al. (2006, 2007,
2009), Di´az-San Segundo et al.
(2009, 2010)
PRRSV: [(+)ssRNA, Arteriviridae] TLR3/7/8/9 and RLRs Viral NSPs target IRF3, IRF7 and ISG3 to suppress IFN
production and signaling; induction of IL-10 and suppression
of IL-12 has been observed
Fang and Snijder (2010),
Yoo et al. (2010),
Calzada-Nova et al. (2010a, b)
*Based on information from PAMs and other cells. ASFV, African swine fever virus; CSFV, classical swine fever virus; HIV1, human immune-deficiency virus-1; HRSV, human
respiratory syncytial virus; IVA: human (swine) Influenza A; SAR, severe acute respiratory syndrome coronavirus; SeV, mouse Sendai virus; PCV2, porcine circovirus-2; PFMDV,
porcine foot-and-mouth disease virus; PRRSV, porcine respiratory and reproductive syndrome virus; PrV, porcine pseudorabies virus. See figure legends for other abbreviations.
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immune suppressive cytokine IL-10 and glucocorticoids
(Martinez et al., 2009; Herbein and Varin, 2010; Odegaard
and Chawla, 2011). In general, M1 macrophages are
pro-inflammatory and induce cellular immunity with
higher microbicidal as well as tissue-destructive activities.
M2a/b cells are anti-inflammatory and induce humoral
immunity with higher anti-parasite, tissue repairing as
well as allergic activities. In contrast, deactivated M2c
macrophages are primarily immunosuppressive along
with secretion of anti-inflammatory cytokines (Martinez
et al., 2009; Herbein and Varin, 2010; Odegaard and
Chawla, 2011). Accumulated evidence indicates that
macrophages are functionally plastic cells with the
potential to alter their activities progressively and
reversibly in response to changes in the tissue environ-
ment (Stout et al., 2009). For example, mouse peripheral
monocytes or peritoneal macrophages shift from M2a
to M2c or from M1 to M2 after sequential treatment
with corresponding cytokines (Stout et al., 2005).
Thus, hypothetically, macrophages at different activation
statuses vary in their antimicrobial activity or capacity to
resolve tissue damage from infections.
The link between macrophage polarization and
virus infection has recently been studied in HIV-1 and
respiratory syncytial virus (RSV)-infected human and
murine cells (Cassol et al., 2009; Shirey et al., 2010). In
vitro polarization of human blood monocytes into M1
cells prevents HIV-1 infection and M2a polarization
inhibits viral replication at a post-integration level but
facilitates macrophage-mediated transmission of HIV-1 to
CD4+ T cells (Cassol et al., 2009). In mice, RSV infection
induces acute inflammatory responses at the early phase,
but macrophages are skewed to the M2 phenotype
progressively during the later phase of infection (Shirey
et al., 2010). This alternative transition of macrophages
counteracts the early inflammatory responses for resolu-
tion of tissue damage, but decreases the higher antiviral
ability associated with the M1 state, which may help
prevent virus escape from innate immune surveillance.
In addition, if the M2 phenotype persists, it may lead to
a ‘Th2-skewed’ adaptive immune response resulting in
hypersensitivity to allergies and autoimmune diseases
(Shirey et al., 2010). The increase of deactivated M2c
macrophages in response to IL-10 and glucocorticoids at a
later phase of viral infection decreases aggressive immune
responses thus limiting pathological damage. However,
some viruses, such as RSV and possibly PRRSV, may
escape this mechanism facilitating the development of
persistent/chronic infection. Therefore, the macrophage
polarization scheme provides a valuable and straightfor-
ward framework for investigating the complexity of host–
virus interaction in macrophages (Herbein and Varin,
2010).
There is broad divergence regarding permissiveness of
porcine macrophages to PRRSV infection and although
the activation status of macrophage subsets is critical in
supporting virus infection and replication, this scheme
has yet to be studied in pigs. In this respect, the
differential expression of virus receptors [including
heparin, sialoadhesin (CD169) and the scavenger receptor
CD163] and immunomodulating cytokines should be
scrutinized in different subsets of macrophages due to
determinants correlating with macrophage activation
and PRRSV permissiveness. Interestingly, in addition to
membrane-bound CD163, a large amount of soluble
CD163 is present in the circulation. It will be informative
to determine how circulating soluble CD163 interacts with
PRRSV (Van Gorp et al., 2008; Patton et al., 2009; Welch
and Calvert, 2010). In addition, an increase of IL-10
and glucocorticoids as well as suppression of IFNs has
been associated with PRRSV infection. It remains to be
determined whether these changes contribute to deacti-
vation of macrophages and thereby to PRRSV pathogen-
esis (Borghetti et al., 2011).
Macrophages are abundant in mucosal membranes
and, unlike DCs, do not migrate to distal tissues. PRRSV
exists in tonsils and lymphoid nodes of infected piglets
and a recent study of vertical transmission has shown that
the targets of PRRSV replication are in the fetal thymus
and presumably are monocytic (Rowland, 2010). There-
fore, macrophages are likely contributors to PRRSV
pathogenesis leading to infected DCs and blood mono-
cytes, which may be more responsible for viral transmis-
sion in lymphatic tissues.
DCs represent a primary group of innate immune
cells that bridge innate and adaptive immune responses
(Iwasaki, 2007; Hammad and Lambrecht, 2008; Wen et al.,
2008). The two major types of DCs are classified as
conventional and plasmacytoid DCs (cDCs and pDCs,
respectively). The cDCs are prominent antigen-presenting
cells with high autophagy activity (a process to uptake an
antigen). Although cDCs are very important in antigen
presentation for T cells in secondary lymphoid tissues, no
direct antiviral role of peripheral cDCs has been defined
in a primary viral infection (Iwasaki, 2007; Hammad and
Lambrecht, 2008). The pDCs are known as natural IFN-
producing cells for their high-level production of IFN-a
after activation, which is essential for inducing a series of
antiviral IFN-stimulated genes (ISGs) and establishing an
antiviral state in surrounding cells (Barchet et al., 2005;
Sen and Sarkar, 2007; Zuniga et al., 2007). To a lesser
extent, pDC also produce TNF-a, IL-6 and IL-12, which
are thought to influence T cells towards a Th1 response
(Barchet et al., 2005). When porcine pDCs are exposed
to viral mimics (such as ligands for TLR7/8 and TLR9)
and viruses [such as pseudorabies (PrV), swine influenza
virus (SIV) and transmissible gastroenteritis coronavirus
(TEGV)], the expression of IFN-a, TNF-a, IL-2, IL-6, and
IFN-g is significantly stimulated; however, production of
IL-12 is only stimulated by the viral mimic and not viruses
themselves. Significantly, the production of all of the
aforementioned cytokines was not observed when pDCs
were exposed to PRRSV, and IL-8 production was not
responsive to both PRRSV and SIV (Calzada-Nova et al.,
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2010a). A small number of viruses, which include
measles virus (MV), human RSV A2 strain and classical
swine fever virus (CSFV), are able to infect DCs and
subvert type I IFN synthesis and/or signaling to some
extent (Table 1). In this regard, PRRSV is capable of
infecting DCs, primarily monocyte-derived DCs (mDCs,
representing mostly cDCs) but not lung DCs. Infection of
mDCs by PRRSV significantly suppresses IFN-a but not
IFN-b production (Loving et al., 2007). PRRSV does not
infect pDCs and the presence of either live or inactivated
PRRSV did not induce IFN-a (Calzada-Nova et al., 2010b).
In addition, PRRSV also inhibits the production of some
pro-inflammatory cytokines including TNF-a and IL-6 but
not IL-8 stimulated by a TLR9 agonist (Calzada-Nova et al.,
2010a). However, CSFV-infected porcine pDCs had sup-
pressed IFN-a production without inhibition of other
cytokines (Carrasco et al., 2004). This suggests that the
production and action of type I IFNs are primary innate
antiviral responses targeted by multiple viruses for
successful infection, whereas modulation of other innate
immune responses are complementary for disease devel-
opment (Table 1).
Cell-based viral recognition mechanisms
As illustrated in Figure 2, the innate immune system,
similar to its adaptive counterpart, comprises both
afferent and efferent arms to discriminate and kill
pathogens (Beutler, 2004). In this context, animal cells
use various receptors to perceive viral infections by
recognizing pathogen-associated molecular patterns
(PAMPs) culminating in the induction of antiviral
responses (Pichlmair and Reis e Sousa, 2007). Prominent
among these receptors are TLRs, which are vertebrate
homologues revealed and named after Drosophila Toll
receptors (West et al., 2006; Takeuchi and Akira, 2007).
TLRs are critical for innate immune recognition and for
inducing immune responses to most microbial infections
(Beutler, 2004; West et al., 2006). Mammalian genome
projects reveal that each mammalian species has approxi-
mately 10 TLRs, which are functional for detection of a
multitude of molecular ligands derived from various
microorganisms (West et al., 2006; Gay and Gangloff,
2007). Six of these TLRs have been instrumental in the
response to viral infection through sensing viral compo-
nents (Akira et al., 2006; Pichlmair and Reis e Sousa, 2007;
Takeuchi and Akira, 2007). Among them, TLR2 and TLR4,
hinged on the cell cytoplasmic membrane, recognize
several viral proteins (Akira et al., 2006; Pichlmair and
Reis e Sousa, 2007; Takeuchi and Akira, 2007). The
functional group of TLR3, TLR7, TLR8 and TLR9 sense
viral nucleic acid, either virus-derived RNA or DNA
molecules (Gay and Gangloff, 2007; Forsbach et al.,
2008). Accordingly, these nucleic acid-sensing TLRs are
responsive mainly in acidified intracellular compartments
including late endosomes and lysosomes, where most
viruses undergo a de-coating process in infection routes
(Pichlmair and Reis e Sousa, 2007). Besides TLR-mediated
viral recognition, mainly in endosomal or lysomal
compartments, animal cells also bear viral recognition
and signaling mechanisms in the cytosol, where most
viruses are obligated to carry out their entire or part of
their infectious cycles (Pichlmair and Reis e Sousa, 2007).
Four cytosol pattern recognition receptors (PRRs), includ-
ing retinotic acid inducible gene I protein (RIG-I),
melanoma differentiation factor-5 (Mda5) and laboratory
of genetics and physiology-2 (LGP2), recognize virus
derived RNA, as well as a cytosol dsDNA sensor named
DNA-dependent activator of IFN regulatory factors (IRFs)
(DAI), have been collectively termed RIG-I-like receptors
(RLRs) (Lee and Kim, 2007; Pichlmair and Reis e Sousa,
2007; Takaoka et al., 2007). These cytosol receptors
recognize distinct molecular patterns of virus-derived
nucleic acids and signal the production of innate immune
IFNs including types I and III IFNs (Takaoka and Yani,
2006, 2007; Onoguchi et al., 2007). Detailed information
about the receptor ligand specificity and antiviral signal-
ing transduction has been reviewed elsewhere (Akira
et al., 2006; Onoguchi et al., 2007; Pichlmair and Reis e
Sousa, 2007; Takeuchi and Akira, 2007; Takaoka et al.,
2007).
Afferent (sensing) arm: 
Collectins, pentraxins, properdin, 
C3b, CD91, natural antibodies*
Humoral 
Efferent (effector) arm:
Cytokines (esp. IFNs), antimicro-
Antiviral innate immunity
bial peptides, natural antibodies*, 
complement (esp. late 
components), acute phase 
reactants
Afferent (sensing) arm:
TLRs (esp. TLR-2, TLR-3, TLR-
4, TLR-7, TLR-8, TLR-9), RIG-I-
like receptors (esp. RIG-I, Mda-5, 
LGP-2), CDS (esp. DAI), PKR, 
GCN2, 2′5′OAS 
Cellular 
Efferent (effector) arm: 
Antimicrobial peptides (AMPs), 
reactive oxygen and nitrogen 
intermediates, IFN-inducible
proteins (esp. Fv, Trim5α, Mx), 
P-eIF2α, RNaseL, deaminases, 
miRNA 
Fig. 2. Afferent and efferent arms of the innate antiviral
immune response. Examples of humoral and cellular
components of innate antiviral immune responses are
indicated. *Natural antibodies belong to the ‘innate’ aspect
of specific immunity. Abbreviations: CDS, cytosolic DNA
sensor; DAI, DNA-dependent activator of IFN-regulatory
factors; GCN2, general control nonderepressible-2; LGP-2,
laboratory of genetics and physiology 2; Mda-5, melanoma
differentiation-associated antigen 5; 2050OAS, 20,50-oligo-
adenylate synthetase; PKR, protein kinase R; RIG-I, retinoic
acid-inducible gene I; TLR, Toll-like receptor; TRIM5a,
tripartite motif protein.
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TLRs are conserved in pigs as indicated from gene
sequences of porcine TLR1–11 (Shinkai et al., 2006a,
2006b; Sang et al., 2008a and unpublished data). In
addition, porcine RIG-I and Mda5 of RLRs and the related
adaptor protein of IFN-b promoter stimulator 1 (IPS-1)
have been identified (Wang et al., 2008; Kojima-Shibata
et al., 2009). Pertaining to PRRSV infection, RNA helicase
RIG-I has been shown to have differential expression in
PRRSV infected tissues (Zhang et al., 2000). We have
shown that transcripts of TLR3, TLR7 and TLR9 are
significantly stimulated in PRRSV infected lungs and
macrophages by the North American type 2 PRRSV (Sang
et al., 2008a, b and unpublished data). Using RNA library
deep sequencing, Xiao et al. (2010a, b) recently showed
that multiple TLRs, RIG-I and Mda5 are stimulated by
an emerged sub-strain of highly virulent Chinese-type
PRRSV, but no stimulation of TLR3 was reported. It is not
clear whether the highly virulent Chinese-type virus has a
mechanism to suppress TLR3 gene transcription.
However, we know that suppression of TLR3 expression
increases PRRSV replication and infection in porcine cells
(Sang et al., 2008b). The antagonism of PRRSV to
inactivate the RIG-I-adaptor protein (i.e. IPS-1) and to
reduce the activation of TLR3-adaptor protein (TRIF) has
been demonstrated in a PRRSV-permissive monkey
kidney cell line (MARC-145) (Luo et al., 2008). Thus,
accumulated evidence shows that PRRSV has evolved to
deviate porcine cells from perceiving and transmitting
antiviral signaling before the production of antiviral
effectors (Figure 3) (Luo et al., 2008; Sang et al., 2008b;
Xiao et al., 2010a, b).
Type I IFNs and other antiviral effectors in
innate immunity
Major classes of innate immune effectors are listed in
Figure 2 and extensively reviewed elsewhere (Beutler,
2004; Klotman and Chang, 2006; Takaoka and Yanai,
2006; Lehrer, 2007; Umbach and Cullen, 2009; Hartshorn,
2010). Two major groups of innate immune effectors, type
I IFNs and antimicrobial peptides (AMPs), and their role
in antiviral responses will be discussed here. Type I IFNs
are prominent in eliciting antiviral responses, and
comprise several subtypes in mammals: IFN-a, IFN-b,
IFN-e, IFN-w and IFN-k (Pestka, 2007). Humans have
multiple IFN-as, and single members of IFN-b, IFN-e, IFN-
k and IFN-w (Takaoka and Yanai, 2006). Additional type I
IFNs include IFN-d, -t and -z (limitin), which are only
detected in pigs and cattle (IFN-d), ruminants (IFN-t) and
mice (IFN-z) (Takaoka and Yanai, 2006).
In pigs, type I IFNs consist of multiple IFN-a, IFN-d and
IFN-w like molecules, such as porcine IFN-a, which are
encoded by as many as 17 functional genes (Sang et al.,
2010a) (Table 2). In addition, pigs have single gene loci
encoding each of IFN-b, IFN-e and IFN-k (Artursson et al.,
1992; Sang et al., 2010a). In most mammalian species,
ubiquitously expressed IFN-a/b are among the most
studied subtypes in antiviral responses. Although less
extensively studied, the tissue-/cell-specific expressed
subtypes, such as IFN-w in various leukocytes, IFN-d/e
in female reproductive tissues and IFN-k in epidermal
keratinocytes, are potently induced by viral infection in
these cell types and confer antiviral states on uninfected
cells (Takaoka and Yanai, 2006; Pestka, 2007). Using a
real-time RT-PCR array, we have detected significant
expression of multiple-type IFN genes in porcine skin,
intestine, lymph nodes, spleen and testis. For example, in
skin, 15 IFN genes belonging to all subclasses are highly
expressed, likely contributing to the skin’s antiviral role as
protection from repetitive exposure to viral attacks
(Table 2). IFNs, except for subclass IFN-a, are highly
expressed in intestine (10 genes) and lymph nodes
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Fig. 3. Interactions between PRRSV and porcine innate
immunity. PRRSV, via non-structural proteins (Nsp) or
nucleocapsid (N) protein, alter antiviral signaling through
suppression of upstream virus perception of type I IFN
production and action. Major virus-targeting factors include
transcription factors that mediate the production/action of
type I IFN and other innate immune antiviral effectors such
as inflammatory cytokines and antimicrobials. Lines with
blunt heads indicate suppression and lines with ball heads
indicate suppression or activation. Abbreviations: AMP,
antimicrobial peptide; AP-1, activator protein 1; Cytk,
cytokine; IFN, interferon; IFNAR, IFN-a receptor; IRF, IFN-
regulatory factor; ISG, IFN-stimulated gene; ISRE, IFN-
stimulated response element; JAK/Tyk2, Janus kinase/
tyrosine-protein kinase 2; NF-kB, nuclear factor kB.
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(9 genes). In contrast, bone marrow cells and liver
showed a relatively weaker expression pattern of type I
IFNs. Relative to subtype differences, IFN-a1/8/12 and
IFN-b are detected in all tested tissues; and porcine IFN-
d5/6/8, IFN-w1/2/3 and single-subtype subclasses IFN-e
and IFN-k are detectable in most tested tissues. IFN-aw, a
unique subtype only found in pigs and cattle, is highly
expressed in porcine skin, but detectable in the intestine,
lymph nodes and spleen, implying an intensification of
IFN response (Sang et al., 2010a) (Table 2).
Type I IFNs are central cytokines in antiviral innate
immunity. The local production of type I IFNs around
infection sites comprises a major antiviral barrier to
inactivate viruses and limit virus spreading. Natural or
modified IFN peptides have been well documented for
various IFN-based antiviral therapies, which are effective
against many viral diseases including viral hepatitis, HIV
and SARS infections (Haagmans and Osterhaus, 2006;
Deutsch and Hadziyannis, 2008; Sulkowski and Benha-
mou, 2007). Type I IFNs, produced during the early phase
of virus-cell interaction, not only activate antiviral
responses via autocrine mechanisms, but also diffuse or
transmit systemically to induce an antiviral state in
surrounding and distal cells. The induction of an antiviral
state, which involves the suppression of cellular meta-
bolic levels of protein synthesis and the profound
expression of genes encoding antiviral products (Haller
and Weber, 2007; Zuniga et al., 2007), is critical for
developing effective immune protection against viral
infections. Type I IFNs collectively induce antiviral
responses through a common receptor composed of two
subunits, IFN-a/b receptor (IFNAR)-1 and IFNAR-2
(Table 2). However, the efficacy for induction of antiviral
responses is different among subtypes and even between
members belonging to the same subtype. For example,
human IFN-as vary in their ability to activate human NK
cells, IFN-b shows more potency than IFN-a2 in inhibi-
tion of monocyte proliferation (Garci´a-Sastre and Biron,
2006; Takaoka and Yanai, 2006). Functional differences
among type I IFNs are related to their diverse affinities
and kinetics in interaction with IFNAR subunits. In
addition, differential expression of each type I IFN and
receptor subunits with regard to tissue/cell types also
contributes to distinct regulation of antiviral responses
(Uze´ et al., 2007).
Porcine IFNs have varying levels of activity against
PRRSV and other viruses in cells. In general, most
subtypes of the IFN-a subclass are highly active against
PRRSV; however, other subclasses including IFN-b, IFN-d,
IFN-e and IFN-k, are not (Sang et al., 2010a). Studies
indicate that IFN-a subtypes are mainly down-regulated
in response to PRRSV infection (Loving et al., 2007; Jung
et al., 2009; Sang et al., 2010a). This suggests that IFN-a
subtypes, not IFN-b, should receive emphasis in the
modulation of porcine anti-PRRSV innate immunity. This
viewpoint is supported by findings showing that PRRSV
isolates differ in their sensitivity to IFN-a suppression (Lee
et al., 2004) and by the recent identification of PRRSV-
diminishing IFN-a production through intervening signal
transducers and activators of transcription (STAT)1–IRF7
signaling in pDCs (Calzada-Nova et al., 2010b).
The interaction of type I IFNs with their receptors leads
to the activation of transcription factors of STATs by two
IFNAR-associated kinases. The activated STAT1, STAT2
and IRF9 form an activator complex of IFN-activated
trimeric transcription factor, ISGF3, which interacts with
the IFN-stimulated response element (ISRE) in promoters
of ISGs to prompt transcription. Hundreds of ISGs have
direct virus targeting functions (e.g. MxA, RNase L and
RNA deaminases), amplifying antiviral resistance (e.g.
PKR, 2050OAS, and type I IFN themselves), and sequestra-
tion of cellular metabolic processes to repress virus
replication (e.g. PKR-mediated arrest of protein synthesis)
(Sen and Sarkar, 2007). It is notable that most notorious
viruses have improved their capability to evade or subvert
the IFN system for their own benefit. Extensive reviews
Table 2. Porcine IFN family members and gene candidates, receptors, number of amino acids, and major expression pattern
Type Subtype
Gene locus and
(number of subtypes) Receptor
Number of
amino acids Major expression pattern
I IFN-a 1q22-q27 (17 and 2yd) IFNAR1 181–189 Ubiquitous expression
IFN-aw 1q22-q27 (1) IFNAR2 185 Skin
IFN-b 1q23-q27(1) 186 Ubiquitous expression
IFN-da SSA1 (11) 153–184 Trophoblast, skin, MLN, Intestine,
skin, MLN and uterus
IFN-e SSA1 (1) 193 Multiple tissues, skin and MLN
IFN-w SSA1 (7 and 2y) 176–190 Intestine, MLN
IFN-k SSA10 (1) 207 Skin
IFN-tb NA
IFN-zc NA
II IFN-g 5p1.2-q1.1/(1) IFNGR1/IFNGR2 166 Activated T cells, NK-cells
III IFN-l1 (IL-29) ? IL-28Ra/IL-10R2 191 Ubiquitous expression
IFN-l2 (IL-28A) NA NA Intestine and MLN
IFN-l3 (IL-28B) SSA14 195
Modified from Chang et al. (2006), Takaoka and Yanai (2006), and Sang et al. (2010a, b). Found only in apigs and cattle,
bruminants, or cmice. dy, pseudo genes; MLN, mesenteric lymph nodes; NA, not applicable.
156 Y. Sang et al.
(Iannello et al., 2006; Haller and Weber, 2007; Loo and
Gale, 2007) on this topic indicate that a collection of virus-
derived factors may interfere with IFN production and/or
IFN-action pathways (Table 1).
In addition to type I IFNs, three type III IFNs (IFN-
l1–l3, also known as IL-29, IL-28A and IL-28B, respec-
tively), have been identified. Accumulated evidence
indicates that type III IFNs are induced through similar
signal transduction pathways as type I IFNs (Ank and
Paludan, 2009). For example, activation of signaling
pathways mediated by TLR3 and RIG-I, which has been
well characterized to induce IFN-a/b production, also
induces type III IFNs in murine and human cells (Ank and
Paludan, 2009). The antiviral activity of human type III
IFNs has been associated with multiple viral infections
including those caused by hepatitis C virus, influenza A
virus and cytomegalovirus (Ank et al., 2006; Ank and
Paludan, 2009). However, type III IFNs are distinct from
type I IFNs in their gene and protein structures as well as
their receptors and expression patterns. For example,
genes of all known mammalian type III IFNs have
multiple exons (usually five) in contrast to the single-
exon genes for type I IFNs (Fox et al., 2009). The protein
structure of human IFN-l3 more closely resembles IL-22
of the IL-10 cytokine family rather than other IFNs (Gad
et al., 2009). Critically, type III IFNs act through cell
receptors of the IL-28RA/IL-10R2 complex rather than the
IFNAR1/IFNAR2 receptors of the type I IFNs (Kotenko
et al., 2003; Sheppard et al., 2003). In addition, type III
IFNs and their receptors are prominent in epithelial
tissues, suggesting their involvement in epithelial antiviral
immunity (Ank and Paludan, 2009). Thus, type III IFNs
comprise a group of newly identified antiviral cytokines
that are functionally similar to type I IFNs and elicit first-
line antiviral responses, especially in epithelial cells. We
have shown that pigs have at least two type III IFNs, IFN-
l1 and IFN-l3, and that both exert similar but lower
activity than IFN-a/b against PRRSV in cells (Sang et al.,
2010b). Non-IFN cytokines, chemokines and AMPs are
other groups of important innate immune effectors
(Figure 2) (Beutler, 2004; Klotman and Chang, 2006;
Pancer and Cooper, 2006; Takaoka and Yanai, 2006;
Lehrer, 2007; Sang and Blecha, 2008; Umbach and Cullen,
2009; Hartshorn, 2010). The innate immune roles of
cytokines and chemokines have been emphasized in
aspects of pro-/anti-inflammation and attraction/activa-
tion of immune cells, which are important for overall
immune responses. Although the antiviral activity of
AMPs has been known for some time (Daher et al., 1986),
research in this area has recently intensified (reviewed in
Klotman and Chang, 2006; Lehrer, 2007). We, along with
others, have demonstrated that PRRSV infection sup-
presses the expression of AMPs and general antimicrobial
activity especially in the lungs of young pigs (Sang and
Blecha, 2009; Sang et al., 2009; Jung et al., 2010). Direct
inactivation of PRRSV by porcine b-defensin (pBD) 3 and
protegrin 4 has also been demonstrated in vitro (Sang
et al., 2009). Animal AMPs exert antiviral activity by
distortion of virion glycoproteins and lipid membranes
in enveloped viruses, and by impeding viral entrance
into host cells. Other mechanisms of AMP antiviral activity
have also been proposed, including down regulation of
viral receptors (e.g. hBD3 for CXCR4 of receptor to HIV-1)
(Feng et al., 2006), modulation of cellular antiviral sig-
naling (e.g. HNP-1 for PKC signaling) (Salvatore et al.,
2007) and potentiating adaptive immunity (Klotman and
Chang, 2006). In addition, other carbohydrate binding
proteins such as collectins, including Mannan-binding
lectin (MBL), surfactant protein A (SP-A), surfactant
protein D (SP-D) and ficolin, have been shown to
participate in innate immune responses exerting antiviral
activity. Recently, a porcine plasma ficolin was reported
to have inhibitory activity against PRRSV replication in a
N-acetylated glycan-dependent manner (Keirstead et al.,
2008). These findings indicate that intervening in the
interaction between sugar moieties of the viral envelope
and host cells is a target for innate immune molecules to
inhibit PRRSV infection (Klotman and Chang, 2006;
Lehrer, 2007).
The interaction of PRRSV and porcine
innate immunity
Aberration of porcine innate immunity by PRRSV
Two decades ago, initial reports of PRRSV occurred
almost simultaneously in the U.S. and central Europe.
These viruses were defined as type 1 European-PRRSV
and type 2 North American-PRRSV. PRRS continues to be
the most significant worldwide swine disease and a
persistent challenge in both immunology and vaccinology
(Kimman et al., 2009; Darwich et al., 2010; Huang and
Meng, 2010; Murtaugh et al., 2010). PRRSV evolves at a
high mutation rate compared with other RNA viruses and
has the potential to subvert host innate immune responses
by various means. These include intervening in cell
recognition of the virus, diverting antiviral cytokine
(especially type I IFNs, IL-1, IL-10 and TNF-a) production
and action, directing cytolysis, reducing antigen presenta-
tion activity and suppressing phagocytic and microbicidal
activity (Darwich et al., 2010; Thanawongnuwech and
Suradhat, 2010; Yoo et al., 2010). The innate immune
aberration could further contribute to inefficiently brid-
ging adaptive immunity, which in cooperation with other
diverting mechanisms on adaptive immunity, causes over-
all immune inefficacy to PRRSV and other co-infections
(Darwich et al., 2010).
Collectively, data show that PRRSV infection leads to
an increase of most if not all viral sensing TLRs in the
lungs or lymphoid organs, including TLR2, TLR3, TLR4,
TLR7, TLR8 and TLR9 (Sang et al., 2008b; Liu et al., 2009;
Xiao et al., 2010a, b). The increased TLR transcripts of
TLR7 and TLR9 may last for at least 1-week post infection
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(Xiao et al., 2010a, b) with TLR2 and TLR4 returning
toward the basal levels after 3-days post infection. It
appears that upregulation of TLR3 is condition-
dependent. The in vitro infection of PAMs and mDCs
(Sang et al., 2008b; Chaung et al., 2010) or in vivo
infection of fetal lungs (Sang et al., 2008b) fails to increase
or even transiently decrease TLR3 expression. Similarly,
no significant increase of TLR3 and TLR8 expression was
found in lungs of pigs infected with the highly virulent
Chinese-type PRRSV (Xiao et al., 2010a, b). Expression of
cytosol virus sensing receptors of RIG-I and Mda5 is also
significantly stimulated in lungs infected by type 2 PRRSV
(Xiao et al., 2010a, b). The increase in these virus-sensing
receptors may potentially lead to antiviral responses.
Overexpression of TLR3 resulted in enhancement and
reduction of TLR3 suppressed anti-PRRSV activity in virus-
infected cells (Sang et al., 2008b). Although it is unknown
whether PRRSV has a mechanism to reduce the expres-
sion of these receptors, the activation of TLR7 and TLR9
signaling in pDCs appears inhibited by the presence of
PRRSV (Calzada-Nova et al., 2010a). The implication of
data using MARC-145 cells is that PRRSV may interfere
with adaptor proteins to suppress both RLR- and TLR3-
mediated stimulation of IFN production (Luo et al., 2008;
Miller et al., 2009). Notably, the acute activation of these
receptor-mediated signaling pathways also leads to
increased production of pro-inflammatory cytokines and
chemokines as well as activation of the complement
systems; this process is thought to be the cause of
pneumonia in PRRS cases (Xiao et al., 2010a). In addition,
the inflammatory response could be amplified in the
presence of bacterial endotoxin (Qiao et al., 2011) or low-
avidity immune complex (Monsalvo et al., 2011) to
promote macrophages skewing to the M2 status (Stout
et al., 2009). Human M2 macrophages show higher
expression of CD163, heparin sulfate and IL-10 (Cassol
et al., 2010); similar responses in pigs could potentially
exacerbate PRRSV infection (Patton et al., 2009; Welch
and Calvert, 2010).
The production and action of the type I IFN system are
hallmarks of innate antiviral immunity. Earlier reports
have shown that pigs infected with PRRSV produce very
low levels of type I IFNs. Exogenous application of IFN-a
could control the virus infection in porcine PAMs and
MARC-145 cells (Albina et al., 1998; Buddaert et al., 1998).
Studies by Lee et al. (2004) showed that different field
isolates and even virus quasi-species rescued from
individual plaque clones of the same isolate vary in their
ability to induce IFN-a and susceptibility to IFN-a
treatment. PRRSV also infects mDCs and significantly
suppresses type I IFN production of the IFN-a subtype
but not the IFN-b subtype (Loving et al. 2007). Extensive
analysis of porcine type I IFN profiles indicates that pigs
have as many as 39 functional genes including 17 IFN-a,
11 IFN-d, 7 IFN-w, as well as a single member of each of
the IFN-aw, IFN-b, IFN-e and IFN-k subtypes (Sang et al.,
2010a). Comparative antiviral analyses in both porcine
PAMs and MARC-145 cells indicate that most IFN-a and
IFN-aw have higher activity against PRRSV infection than
do other subtype members (Sang et al., 2010a).
Determined by the stability of the ternary IFN-receptor
complex, type I IFNs biological activities proceed in two
directions, antiviral activity and immunomodulatory
activity (Uze´ et al., 2007; Kalie et al., 2008). Whereas
IFN-a subtypes generally have more antiviral potency,
IFN-b displays more immunomodulatory activity such as
promotion of cell proliferation (Kalie et al., 2008). Recent
studies have shown that IFN-b has anti-inflammatory
properties inducing IL-10 production in human mDCs
(Wang et al., 2011) and regulating alternative activation of
macrophages through induction of IL-4, IL-13 and IL-10 in
RSV infected murine lungs (Shirey et al., 2010). Interest-
ingly, PRRSV suppression of IFN-b production through
targeting IRF3 has been mostly observed in MARC-145
cells or experimental human cell lines (Miller et al., 2004;
Luo et al., 2008; Shi et al., 2010; Chen et al., 2010a; Kim
et al., 2010; Li et al., 2010; Beura et al., 2010; Song et al.,
2010). These observations are not always consistent with
the data from infected pigs or porcine cells (Loving et al.,
2007; Genini et al., 2008). In contrast, in vivo or ex vivo
tests in porcine lungs strongly support PRRSV-mediated
IFN-a suppression in porcine lungs (Jung et al., 2009),
PAMs (Albina et al., 1998; Genini et al., 2008; Patel et al.,
2010), mDC (Loving et al., 2007) and pDCs (Calzada-Nova
et al., 2010a, b).
Cell type difference in respect to response to PRRSV
mediated IFN-suppression has recently been noted
(Loving et al., 2008; Sang et al., 2010a; He et al., 2011).
In addition, the suppression of IFN-d or IFN-w (termed
SPI IFN in the reference) has also been observed (Xiao
et al., 2010b; Sang, unpublished data); therefore, whether
all type I IFNs are generally suppressed or differentially
regulated by PRRSV in vivo to facilitate virus infection
should be determined. PRRSV suppresses type I IFN
signaling primarily in infected cells, as indicated by
suppression of ISG15 and ISG56 in PRRSV infected
MARC-145 and PAMs (Patel et al., 2010). However,
exogenous application of IFNs does prevent PRRSV-
suppression of IFN signaling due to the treatment of PAMs
with either porcine type I, II or III IFNs, and especially
IFN-a, which induce significant anti-PRRSV activity
(Rowland et al., 2001; Sang et al., 2010a, b).
PRRSV infection also diverts the production of other
cytokines and antimicrobial molecules, such as AMPs
and nitric oxide (NO). However, reports regarding PRRSV
regulation of cytokines are quite controversial. Both in-
creases and decreases of pro-inflammatory cytokines such
as TNF-a, IL-1 and IL-6, have been shown in PRRSV
infected pigs and PAMs (Darwich et al., 2010). PRRSV
does prevent the production of IL-8 (Calzada-Nova et al.,
2010a) in pDCs but other studies have found that PRRSV
induces IL-8 (Darwich et al., 2010). More extensive
cytokine analyses have linked IL-1b, IL-8 and IFN-g but
not IL-12 with PRRSV clearance (Lawson et al., 2010;
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Lunney et al., 2010). IL-10 is an immunosuppressive
cytokine, which is up-regulated by PRRSV infection
(Thanawongnuwech and Suradhat, 2010) and induces
PAM permissiveness to PRRSV (Patton et al., 2009).
Similar to the regulation of other cytokines, PRRSV
infected pigs or cells have been shown to have either
increased or decreased IL-10 production (Klinge et al.,
2009; Darwich et al., 2010; Subramaniam et al., 2011).
Therefore, as suggested by studies of Di´az et al. (2006)
and Silva-Camp et al. (2010), PRRSV-regulation of IL-10
may be both pig- and virus-strain dependent. Studies
evaluating PRRSV-suppression of antimicrobial and
phagocytic activities are consistent in virus-infected lungs
and PAMs, showing that, in general, PRRSV decreases the
production of AMPs and NO, and suppresses the
microbicidal activity of both PAMs and NK cells (Thana-
wongnuwech et al., 2000; Jung et al., 2009; Sang et al.,
2009). PRRSV also directs cytolysis in infected PAMs
and mDCs and cell death is prominent in activated M2
macrophages (unpublished data). The suppression of
microbicidal activity and direction of cell death of innate
immune cells at the cellular and molecular levels may be
linked to co-infections with PRRSV.
Viral mechanisms responsible for innate
immune aberration
PRRSV is an enveloped virus, which has a 15 kb
(+)ssRNA genome containing nine open reading frames
(ORF). The 50 end ORF1a and ORF1b encode two
replicase polyproteins, pp1a and pp1b. The proteolytic
pp1a products self cleave into nine non-structural
proteins (Nsp) (Nsp1a, Nsp1b and Nsp2–8), and cleave
pp1b into four Nsp (Nsp9–12). The 30 end seven ORFs
encode four minor (GP2a, GP3, GP4 and E proteins) and
three major (GP5, M and N proteins) structural proteins.
Besides their essential role in viral replication, recent
studies highlight the roles of the Nsp in immune
modulation of innate immune effectors (Fang and Snijder,
2010; Yoo et al., 2010). Four viral Nsp have strong to
moderate inhibitory effects (Nsp1>Nsp2>Nsp11>Nsp4) on
IFN-b production through inactivating IRF3, which is a
key transcription factor responsible for activation of the
IFN-b promoter (Beura et al., 2010).
Nsp1 and its two autocleaved products, Nsp1a and
Nsp1b, have been shown to have the highest activity
inhibiting IRF3 activation (Beura et al., 2010; Yoo et al.,
2010). Beura et al. (2010) indicated that Nsp1a and Nsp1b
block IRF3 nuclear translocation; however, Yoo et al.
(2010) observed no blocking of Nsp1a and Nsp1b in IRF3
nuclear translocation, and proposed a mechanism based
on Nsp1 promoting degradation of the CREB (cyclic AMP
response element binding)-binding protein (CBP). CBP
has histone acetyltransferase activity functioning in
dissociation of histones from the DNA promoter region,
and the CBP/p300 co-activators function in concert with a
variety of transcription factors including STATs, NF-kB,
PIAS1 and the IRF family (Yoo et al., 2010). Nsp1-
mediated CBP-degradation may provide a general expla-
nation of PRRSV immune suppression via interaction with
IRF3 as well as STAT2, because the decrease in STAT2 at
the protein level has been reported in PRRSV-infected
cells (Patel et al., 2010). In another report, both Nsp1a
and Nsp1b were shown to dramatically inhibit IFN-b
expression and Nsp1b also suppressed IFN signaling via
inhibiting STAT1 nuclear translocation (Chen et al.,
2010a). Patel et al. (2010) further demonstrated that
STAT1 is not the only factor inhibited as nuclear
translocation of ISGF3 (ISG factor 3, composed by
STAT1/STAT2/IRF9) was also inhibited by Nsp1b to
suppress IFN-a signaling in the virus-infected cells.
PRRSV does not infect pDCs, but the presence of some
uncharacterized viral component blocks STAT1 nuclear
localization thereby reducing the availability of IRF7,
which has been thought to be a mechanism for PRRSV
inhibition of IFN-a production in pDCs (Calzada-Nova
et al., 2010b). Nsp1a and Nsp1b also block NF-kB
activation (Song et al., 2010), a critical transcription factor
in innate immune signaling not only for antiviral
responses; therefore, Nsp1 proteins may also be the viral
components responsible for suppressing other cytokines
and AMPs in addition to IFNs (Figure 3).
PRRSV Nsp2 represents another major immunomodu-
latory protein (Fang and Snijder, 2010). The region of
691–722 residues in Nsp2 has been shown to be important
for virus mediation of production of pro-inflammatory
cytokines including IL-1b and TNF-a (Chen et al., 2010b).
Biochemically, Nsp2 belongs to the deubiquitinase super-
family; through this activity, it can interfere with the
polyubiquitination process of ISG15 and IKKa (inhibitor
of nuclear factor kappa-B kinase (NF-kB) subunit a),
thereby targeting the IFN response and NF-kB signaling
pathways respectively (Sun et al., 2010).
PRRSV Nsp11 also has dual roles in suppression of IFN
responses (Yoo et al., 2010) and reduction of NF-kB
activation (Beura et al., 2010). Nsp11 has endo-RNase
activity; its suppression of IFN response may partially be
due to cleavage of viral RNA patterns to dampen the
binding by multiple cellular antiviral receptors including
TLR3/7/8/9, RIG-I, and Mda5, thus reducing the upstream
viral sensing in antiviral signaling (Yoo et al., 2010). In
addition, Nsp11 has been shown to block IRF3 phos-
phorylation and nuclear translocation (Yoo et al., 2010),
but it is unclear whether this resulted from weakened
upstream signaling (i.e., diminishing dsRNA binding) or
Nsp11 targeting IRF3 directly through other mechanisms.
As previously mentioned, PRRSV has been reported to
strongly induce IL-10 production during the early phase
of infection in pigs (Thanawongnuwech and Suradhat,
2010) and in cultured porcine PBMCs and PAMs (Yoo
et al., 2010). The viral mechanism to induce IL-10 is
reported to be the nucleocapsid (N) protein (Yoo et al.,
2010). The N protein is a small basic protein of 123 (or 128
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of type I PRRSV) residues and it is the most abundant
virion component and the most immunogenic protein in
virus-infected pigs and cells (Music and Gagnon, 2010).
The mechanism of N protein induction of IL-10 is
unknown. Given that nucleolus-localized N protein
interacts with several cell transfactors (Yoo et al., 2010),
there is potential of the N protein directly targeting the IL-
10 gene promoter. In addition, recent evidence shows
that IFN-b, produced from LPS activation of macrophages
or DCs, induces IL-10 in these cells (Chang et al., 2007;
Wang et al., 2011). The N protein may activate the NF-kB
pathway to induce IFN-b production through TLR4
activation of NF-kB pathways, therefore, inducing IL-10
stimulation and NF-kB activation with LPS-TLR4 signaling
(Chang et al., 2007; Wang et al., 2011). This assumption
is supported by the understanding that N protein
does activate NF-kB in MARC-145 cells and the region
between residue 30–73 of N protein is essential for
this function (Luo et al., 2011), and TLR4 is induced in
PRRSV infected pigs (Xiao et al., 2010a). Integrating the
points of N protein activation of NF-kB, LPS-TLR4
mediated IFN-b production and IL-10 induction by IFN-
b explains several controversial observations such as the
induction/no-induction of IFN-b and IL-10 as well as
the activation/suppression of NF-kB in PRRSV infected
pigs or cells. Therefore, the consequent levels of IFN-b
and IL-10 (and probably other innate immune effectors
too) are not only dependent on PRRSV infection but also
the activation of LPS-TLR4 signaling by some bacterial
endotoxins; and the suppression or activation of NF-kB
signaling should be variable according to the intensity
and tempo between the N protein’s positive and Nsp’s
negative effects. In summary, innate immune deficiency
caused by PRRSV infection complicates the viral disease
creating a complex syndrome. The challenge faced is not
only from the small virus per se, but mostly, if not always,
from the interaction of other opportunistic infections in a
host with a disruption in homeostasis.
Concluding remarks
In Figure 4, we briefly summarize our understanding of
PRRSV diversion of innate immunity at the levels of the
animal, cell and molecule. We propose that through viral
parasitization and interaction to deviate the expression
and/or activation states of innate immune molecules,
PRRSV alters the environment for development/activation
of innate immune cells, and particularly dominates the
functional status of monocytic cells including tissue
macrophages and circulating DCs by direct infection or
standby suppression in pDCs. The viral aberration of
innate immunity has been shown at the cellular level in
two aspects. Firstly, the skewing or adapting of innate
immune cells to the status of anti-inflammation and
immunosuppression at the early phase of infection, such
as the M2 status of macrophages, which are observed to
be more permissive to PRRSV infection than M1 cells
(Patton et al., 2009; Sang, unpublished data). Secondly,
there is suppression of immune surveillance including
dampened microbicidal and antigen processing activity in
DCs and macrophages (Sang et al., 2009; Jung et al., 2009;
Thanawongnuwech and Suradhat, 2010).
Pertaining to the characteristics of tissue- or cell-tropism,
the primary sites of PRRSV infection, including reproduc-
tive and pulmonary tissues, contain monocytic cells that
are naturally inclined to a M2 or immunosuppressive
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Fig. 4. Tactics to counteract PRRSV deviation of porcine innate immunity at the molecular, cellular and animal levels. Viral
aberration is indicated in the top portion of the figure. Vector-based expression or suppression of the virus-aberrant antiviral
effectors (or signaling molecules) may work alone or in concert with a subunit vaccine to stimulate effective anti-PRRSV
protection. Innate immune cells, especially PRRSV-infected monocytic cells, are platforms to manipulate virus-aberrant cell
activation status and innate immune response. In pigs, drug-based approaches to modulate inflammatory and lipid metabolic
status may be feasible to alter host response to vaccination or infection.
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status, especially those in the reproductive tissues with
immune privilege. This viewpoint suggests that PRRSV
has evolved to adapt rather than skew innate immune
cells to establish an infection at the animal level, and the
high-virulence PRRSV strains, which cause significant host
mortality because of the dramatic inflammatory response
(Xiao et al., 2010a), are unique cases of unsuccessful
parasitization. Therefore, the suppression of M1 activation
especially antiviral status induced by type I IFNs in innate
immune cells during the early phase of infectionmight be a
key for designing counteractions to target PRRSV infection
at both cell and animal levels. However, unlike in ex vivo
cells, time and intensity are more critical for the success of
inflammatory and immune regulation in vivo (Figure 4). In
this line, some herbal therapies, which have been shown
effective in treatment of inflammatory symptoms in SARS
(Leung, 2007) and pandemic influenza (Ge et al., 2010),
are worth evaluating in PRRSV pandemics. In addition,
lipid metabolites such as sphingosine-1-phosphate (S1P)
have been known for critical regulation of inflammation
and immune cell recruitment/activation (Spiegel and
Milstien, 2011). Several recent studies elegantly linked
lipid metabolism to immune status of macrophages (Im
et al., 2011), T cells and DCs (Herber et al., 2010), as well
as cytokine storms in influenza-infected lungs (Teijaro
et al., 2011). It will be informative to examine the role of
modulators/metabolites of lipid metabolism in regulation
of inflammatory and immune status during PRRSV infec-
tion and vaccine development.
Finally, the development of vaccines to induce effective
protection against heterologous PRRSV isolates should be
focused at the cellular and molecular levels. To this end,
the adjuvant mechanisms underlying innate immunity
(Coffman et al., 2010) should be considered in respect to
PRRSV-diverted innate immune components as reviewed
above. Positive effects have been obtained in studies with
expression of IFN-a alone (Brockmeier et al., 2009) or
conjugated expression of innate immune effectors includ-
ing CD40L (Cao et al., 2010), GM-CSF (Wang et al., 2009)
and HSP70 (Li et al., 2009b) with the viral epitopes
using adenovirus vectors. In addition, several studies
using RNA interference techniques have shown promise
in suppression of PRRSV infection in both cells and pigs
(Lu et al., 2006; Li G et al., 2009a), implying that miRNA-
mediated antiviral mechanisms, which have been found
in regulation of HCV and HIV infection (Skalsky and
Cullen, 2010), could be also functional in PRRSV-host
interaction. Viruses are dependent on cell metabolism
and genome-wide screening of host factors critical for
host–viral interaction has revealed a large number of
candidates belonging to metabolic pathways besides
immune genes (Karlas et al., 2010; Ko¨nig et al., 2010).
To this end, it is likely that aberration of lipid metabolism
is a major consequence in PRRSV-host interaction (Xiao
et al., 2010b) and the regulation of lipid signaling has
potential to prime activation status and immune surveil-
lance of innate immune cells. In summary, to induce
ideal anti-PRRSV protection, strategies should be con-
sidered for targeting innate immune components to
counteract viral replication/spreading and subversion of
immunity as well as to mitigate immune pathology from
excessive/persistent activated innate immune responses
(Figure 4).
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